Evaluation and Analysis of Risk Factors of Hearing Impairment for Nasopharyngeal Carcinoma treated using Intensity-Modulated Radiotherapy

Post-irradiation endolymphatic hydrops vs. post-irradiation sudden deafness

(2022) Chung-Tang Tien et al.   RADIOTHERAPY AND ONCOLOGY

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Impact of cumulative cisplatin dose and adjuvant chemotherapy in locally-advanced nasopharyngeal carcinoma treated with definitive chemoradiotherapy

(2020) Marc Oliva et al.   ORAL ONCOLOGY

Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy response

(2019) Sai-Lan Liu et al.   RADIOTHERAPY AND ONCOLOGY

Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy

(2019) David M. Baguley et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Time course and clinical characterization of cisplatin-induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population

(2018) Sze Ling Chan et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Long Term Late Toxicity, Quality Of Life and Emotional Distress In Nasopharyngeal Carcinoma Patients Treated With Intensity-Modulated Radiotherapy

(2018) Lachlan J. McDowell et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Late Sequelae of Childhood and Adolescent Nasopharyngeal Carcinoma Survivors after Radiotherapy

(2018) Suying Lu et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Optimizing the cumulative cisplatin dose during radiotherapy in nasopharyngeal carcinoma: Dose-effect analysis for a large cohort

(2018) Liang Peng et al.   ORAL ONCOLOGY

Global trends in nasopharyngeal cancer mortality since 1970 and predictions for 2020: Focus on low-risk areas

(2017) Greta Carioli et al.   INTERNATIONAL JOURNAL OF CANCER

Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer

(2016) Robert D. Frisina et al.   JOURNAL OF CLINICAL ONCOLOGY

Hearing and tinnitus in head and neck cancer patients after chemoradiotherapy

(2015) Riina Niemensivu et al.   EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

Normal tissue complication probability modeling for cochlea constraints to avoid causing tinnitus after head-and-neck intensity-modulated radiation therapy

(2015) Tsair-Fwu Lee et al.   Radiation Oncology

Sensorineural Hearing Loss after Combined Intensity Modulated Radiation Therapy and Cisplatin-Based Chemotherapy for Nasopharyngeal Carcinoma

(2015) Jin Wang et al.   Translational Oncology

Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma

(2015) Ji-Jin Yao et al.   Scientific Reports

Prediction of Hearing Loss Due to Cisplatin Chemoradiotherapy

(2015) Eleonoor A. R. Theunissen et al.   JAMA Otolaryngology-Head & Neck Surgery

Ototoxicity in Children With High-Risk Neuroblastoma: Prevalence, Risk Factors, and Concordance of Grading Scales—A Report From the Children's Oncology Group

(2014) Wendy Landier et al.   JOURNAL OF CLINICAL ONCOLOGY

Risk Factors for Hearing Loss in Patients Treated With Intensity-Modulated Radiotherapy for Head-and-Neck Tumors

(2009) Charlotte L. Zuur et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

A study of middle ear function in the treatment of nasopharyngeal carcinoma with IMRT technique

(2009) Sheng Zi Wang et al.   RADIOTHERAPY AND ONCOLOGY

Prevalence of Hearing Loss and Differences by Demographic Characteristics Among US AdultsData From the National Health and Nutrition Examination Survey, 1999-2004

(2008) Yuri Agrawal   ARCHIVES OF INTERNAL MEDICINE